|
TMEM182 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.598000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.285700E-02 |
| Normal-vs-Stage2 |
4.743500E-02 |
| Normal-vs-Stage3 |
6.821900E-03 |
| Normal-vs-Stage4 |
5.836200E-04 |
| Stage1-vs-Stage2 |
3.551000E-01 |
| Stage1-vs-Stage3 |
8.374000E-02 |
| Stage1-vs-Stage4 |
3.237700E-02 |
| Stage2-vs-Stage3 |
6.603200E-01 |
| Stage2-vs-Stage4 |
2.691000E-01 |
| Stage3-vs-Stage4 |
4.450200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.800400E-04 |
| Normal-vs-AfricanAmerican |
4.720800E-03 |
| Normal-vs-Asian |
7.006000E-02 |
| Caucasian-vs-AfricanAmerican |
7.866400E-01 |
| Caucasian-vs-Asian |
8.439600E-01 |
| AfricanAmerican-vs-Asian |
9.248600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.629700E-02 |
| Normal-vs-Female |
1.75018999999388E-05 |
| Male-vs-Female |
2.701900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.757700E-02 |
| Normal-vs-Extreme_Weight |
1.417770E-01 |
| Normal-vs-Obese |
9.376500E-04 |
| Normal-vs-Extreme_Obese |
5.760200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.645800E-01 |
| Normal_Weight-vs-Obese |
1.554630E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.198800E-01 |
| Extreme_Weight-vs-Obese |
2.271700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.728400E-01 |
| Obese-vs-Extreme_Obese |
2.545000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.211900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.398500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.046120E-02 |
| Normal-vs-Age(81-100Yrs) |
4.136000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.458590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.119500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.268200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.619620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.358370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.824000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.557840E-03 |
| Normal-VS-Type2 PRCC |
3.472000E-02 |
| Normal-VS-KIRP CIMP |
1.241480E-03 |
| Normal-VS-Unclassified PRCC |
7.177900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.322000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.621900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.540600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.496200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.628800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.119710E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.115200E-01 |
| Normal-vs-N1 |
3.903700E-03 |
| Normal-vs-N2 |
9.72860000000297E-05 |
| N0-vs-N1 |
2.575600E-02 |
| N0-vs-N2 |
7.099600E-03 |
| N1-vs-N2 |
4.442200E-01 |
|
|
